Press Releases March 30, 2026 08:00 PM

Precision Drilling Corporation 2026 First Quarter Results Conference Call and Webcast

Precision Drilling Announces Schedule for 2026 Q1 Results and Investor Conference Call

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
PDS

Precision Drilling Corporation has announced it will release its 2026 first quarter financial results on April 29, 2026, with a follow-up conference call scheduled for April 30. The company provides advanced drilling and environmental solutions with a focus on digital technologies and sustainability. The webcast and replay will be accessible for investors and interested parties.

Precision Drilling Corporation 2026 First Quarter Results Conference Call and Webcast
PDS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Precision Drilling plans to release Q1 2026 earnings and host a conference call for investors.
  • The company highlights its advanced drilling services, digital technology portfolio (Alpha™), and environmental solutions (EverGreen™).
  • Precision is listed on both the TSX (PD) and NYSE (PDS), serving the energy sector with high-performance rig services.

CALGARY, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (Precision) intends to release its 2026 first quarter results after the market closes on Wednesday, April 29, 2026, and has scheduled a conference call to begin at 11:00 a.m. MT (1:00 p.m. ET) on the next day, Thursday, April 30, 2026.

To participate in the conference call please register at the URL link below. Once registered, you will receive a dial-in number and a unique PIN, which will allow you to ask questions.

https://register-conf.media-server.com/register/BI8811660f92894f7aa14eca5d58cbc0df

The call will also be webcast and can be accessed through the link below. A replay of the webcast call will be available on Precision’s website for 12 months.

https://edge.media-server.com/mmc/p/952icqoy

About Precision

Precision is a leading provider of safe and environmentally responsible High Performance, High Value services to the energy industry, offering customers access to an extensive fleet of Super Series drilling rigs. Precision has commercialized an industry-leading digital technology portfolio known as Alpha™ that utilizes advanced automation software and analytics to generate efficient, predictable, and repeatable results for energy customers. Our drilling services are enhanced by our EverGreen™ suite of environmental solutions, which bolsters our commitment to reducing the environmental impact of our operations. Additionally, Precision offers well service rigs, camps and rental equipment all backed by a comprehensive mix of technical support services and skilled, experienced personnel.

Precision is headquartered in Calgary, Alberta, Canada and is listed on the Toronto Stock Exchange under the trading symbol “PD” and on the New York Stock Exchange under the trading symbol “PDS”.

Additional Information

For more information about Precision, please visit our website at www.precisiondrilling.com or contact:

Lavonne Zdunich, CPA, CA
Vice President, Investor Relations
403.716.4500

800, 525 - 8th Avenue S.W.
Calgary, Alberta, Canada T2P 1G1
Website: www.precisiondrilling.com


Risks

  • Market volatility in the energy sector could impact financial results.
  • Environmental regulations and operational risks in drilling activities may affect business performance.
  • Dependence on adoption and effectiveness of digital technology solutions in a competitive market.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026